DILAN IPEK: Open Payments
NPI 1952188633 · CASSELBERRY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 54 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $381 · 2025 $1,535
Food & beverage: $1,440Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $303 |
| ABBVIE INC. | 14 | $277 |
| Amgen Inc. | 4 | $202 |
| MAYNE PHARMA COMMERCIAL LLC | 11 | $167 |
| REVANCE THERAPEUTICS, INC. | 1 | $148 |
| Regeneron Healthcare Solutions, Inc. | 2 | $141 |
| UCB, Inc. | 6 | $139 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Organon LLC | 1 | $26 |
| Almirall LLC | 1 | $26 |
Products named: TREMFYA, SKYRIZI, OTEZLA, DAXI, DUPIXENT, Bimzelx, Sotyktu, Seysara.
Industry payments across FL — which companies pay providers there.
